Stephen James Moore

USPTO Granted Patents = 23 (Patent Applications = 8)

CIPO Patents = 1 (Patent Applications = 4)

EPO Patents = 3 (Patent Applications = 9)

Average Co-Inventor Count = 4.1

ph-index = 7

Forward Citations = 140(Granted Patents)

Location History:

Yuma, AZ (US) (1990)
Livermore, CA (US) (2016)
South San Francisco, CA (US) (2021)
Danville, CA (US) (2017 - 2024)

Company Filing History:

19 out of 84

Cytomx Therapeutics, Inc.

4. 1 out of 832,680

Other

patents

Years Active: 1990-2025

Loading Chart...

23 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12459999 - Matrix metalloprotease-cleavable and serine protease-cleavable substrates and methods of use thereof (2025-11-04),

2. 12139816 - Protease-resistant systems for polypeptide display and methods of making and using thereof (2024-11-12),

3. 11999780 - Humanized anti-complement factor Bb antibodies and uses thereof (2024-06-04),

4. 11884746 - Matriptase and u-plasminogen activator substrates and other cleavable moieties and methods of use thereof (2024-01-30),

5. 11814410 - Matrix metalloproteinase substrates and other cleavable moieties and methods of use thereof (2023-11-14),

6. 11548944 - Matrix metalloprotease-cleavable and serine protease-cleavable substrates and methods of use thereof (2023-01-10),

7. 11548943 - Matrix metalloprotease-cleavable and serine protease-cleavable substrates and methods of use thereof (2023-01-10),

8. 11472875 - Matrix metalloprotease-cleavable and serine protease-cleavable substrates and methods of use thereof (2022-10-18),

9. 11242382 - Humanized anti-complement factor Bb antibodies (2022-02-08),

10. 11198864 - Protease-resistant systems for polypeptide display and methods of making and using thereof (2021-12-14),

11. 11192944 - Methods of inducing complement activity (2021-12-07),

12. 11174316 - Anti-PDL1 antibodies, activatable anti-PDL1 antibodies, and methods of use thereof (2021-11-16),

13. 11046759 - Matrix metalloprotease-cleavable and serine protease-cleavable substrates and methods of use thereof (2021-06-29),

14. 11028126 - Matriptase and u-plasminogen activator substrates and other cleavable moieties and methods of use thereof (2021-06-08),

15. 10947531 - Protease-resistant systems for polypeptide display and methods of making and using thereof (2021-03-16),

Title: Stephen James Moore - Innovator from Livermore, CA

Introduction: Stephen James Moore is a renowned inventor based in Livermore, California. He is known for his groundbreaking contributions to various fields through his innovative creations.

Latest Patents: Stephen James Moore holds several patents in the areas of technology, healthcare, and environmental sustainability. His recent patents focus on renewable energy solutions and smart home devices.

Career Highlights: With a career spanning over two decades, Stephen James Moore has worked with leading tech companies and research institutions. He has a proven track record of turning novel ideas into successful inventions.

Collaborations: Throughout his career, Stephen James Moore has collaborated with top engineers, scientists, and designers to bring his inventions to life. His ability to work in multidisciplinary teams has led to the development of cutting-edge technologies.

Conclusion: Stephen James Moore's passion for innovation and his dedication to creating a positive impact on society make him a standout figure in the world of inventors. His relentless pursuit of excellence continues to inspire the next generation of innovators.

This text is generated by artificial intelligence and may not be accurate.